Ascendis Pharma A (ASND) Construction in Progress (2018 - 2021)

Ascendis Pharma A has disclosed Construction in Progress across 4 years of filings, most recently posting $2173.5 for Q4 2021.

• Construction in Progress for Q4 2021 came in at $2173.5, down 20.74% year-over-year; the trailing twelve-month figure through Dec 2021 was $2173.5 (down 20.74% YoY), and the FY2021 annual result was $2173.5, down 20.74% from the prior year.
• Construction in Progress came in at $2173.5 for Q4 2021 at Ascendis Pharma A, down from $2742.3 in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $3.0 million in Q4 2019 to a low of $2173.5 in Q4 2021.
• The 4-year median for Construction in Progress is $115510.8 (2018), against an average of $805448.0.
• Across the five-year window, Construction in Progress jumped 1209.18% in 2019 and plunged 99.91% in 2020, its largest moves.
• Ascendis Pharma A's Construction in Progress stood at $228279.3 in 2018, then surged by 1209.18% to $3.0 million in 2019, then slumped by 99.91% to $2742.3 in 2020, then decreased by 20.74% to $2173.5 in 2021.
• The last three Construction in Progress figures came in at $2173.5 (Q4 2021), $2742.3 (Q4 2020), and $3.0 million (Q4 2019), per Business Quant data.